Common Diabetes Drug Invokana (canagliflozin) May Also Shield Kidneys, Heart

MONDAY, April 15, 2019 — A common diabetes drug may also greatly reduce the odds for death from kidney failure and heart disease in diabetes patients with kidney disease, a new study finds.
The news on Invokana (canagliflozin) is important,…
Source: Topamax